Sept 24 (Reuters) - Sanofi (SASY.PA), opens new tab has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion ...

(Reuters) - Sanofi has received two separate bids for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion) or more, from private equity firms Clayton Dubilier ...

Also Read: Sanofi’s Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows. Sarclisa is the first anti-CD38 therapy in combination with standard-of-care VRd ...

The Bell County Sheriff’s Foundation is ready to tee off for a good cause this month. The Johnson Brothers Ford 11th annual Police Memorial Golf Tournament is scheduled for Sept. 30 with lunch ...

Sanofi’s SNY stock has gained 22.7% in the past three months compared with an increase of 2.9% for the industry. The stock has also outperformed the sector and the S&P 500 index as seen in the ...

After allegedly paying nearly $400,000 for a ransom in May, AT&T is reaching for its wallet again. This time, it’s to settle a cloud breach investigation led by the FCC. In a press release on ...

Panacea Biotec has resolved a patent infringement lawsuit with Sanofi Healthcare concerning its EasySix hexavalent vaccine. Under the settlement, Sanofi will refrain from launching its Shan6 ...

Panacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its opposition to ...

Because of increased costs, the procurement for the maintenance of Riga’s bridges was ended abruptly, said Riga City CEO Jānis Lange at a press-conference on Wednesday, the 18th of September. He said ...

Panacea Biotec share price was locked in upper circuit in Tuesday's trading session after the company announced that it has entered into a settlement agreement with Sanofi Healthcare India over ...

Shares of Panacea Biotec Ltd. hit the 5% upper circuit to touch the highest level in over three years on Tuesday as the company reached a settlement agreement with Sanofi Healthcare India Pvt. over a ...

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.